Does the use of Prokrab-L lead to increased risk of fractures?
Nov 4, 2023
Does the use of Prokrab-L lead to increased risk of fractures?
Numerous investigations conducted on adults have provided evidence indicating that the administration of ProkrabL might be linked to a heightened susceptibility to osteoporosisrelated fractures occurring in the hip wrist or spine This risk of fracture was notably amplified in individuals subjected to higher dosage regimens When referring to high dose it typically encompasses the administration of multiple daily doses and extended treatment durations lasting a year or more These findings underline the importance of cautious consideration when prescribing ProkrabL especially in patients requiring prolonged therapy or higher dosages as they appear to be more vulnerable to the potential adverse effects on bone health Healthcare professionals should exercise vigilance and closely monitor individuals receiving ProkrabL treatment particularly those with preexisting risk factors for osteoporosis or who are more susceptible to fractures to mitigate the likelihood of such detrimental outcomes Consequently a comprehensive evaluation of the patients medical history and individual risk factors becomes imperative in order to make informed decisions regarding the appropriate course of treatment and to implement appropriate measures to mitigate the risk of osteoporotic fractures associated with ProkrabL therapy
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹130₹260
₹237₹263
₹189₹210
₹144₹160
₹328₹365
₹146₹162
₹255₹283
₹111₹123
₹135₹150